Amicus Therapeutics(FOLD) - 2024 Q2 - Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Andrew Faughnan - Vice President, Investor Relations Bradley Campbell - President and CEO Sebastien Martel - Chief Business Officer Dr. Jeff Castelli - Chief Development Officer Simon Harford - Chief Financial Officer Dr. Mitchell Goldman - Chief Medical Officer Ellen Rosenberg - Chief Legal Officer Conference Call Participants Tazeen Ahmad - BofA Securities Ellie Merle - UBS Anupam Rama - ...